Renaissance Technologies (RenTech)'s CDNA Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC (Rentech)) currently holds 1.11 M shares of CareDx, Inc. (CDNA) worth $20.82 M, representing 0.03% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 32 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in CDNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 636,300 shares. Largest reduction occurred in Q3 2024, reducing 276,800 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s CareDx (CDNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly CareDx (CDNA) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -50,400 | Reduce 4.36% | 1.11 M | $18.84 |
| Q3 2025 | -100 | Reduce 0.01% | 1.16 M | $14.54 |
| Q2 2025 | -81,300 | Reduce 6.57% | 1.16 M | $19.54 |
| Q1 2025 | -195,200 | Reduce 13.63% | 1.24 M | $17.75 |
| Q4 2024 | +196,298 | Add 15.88% | 1.43 M | $21.41 |
| Q3 2024 | -276,800 | Reduce 18.30% | 1.24 M | $31.23 |
| Q2 2024 | +88,100 | Add 6.18% | 1.51 M | $15.53 |
| Q1 2024 | +62,500 | Add 4.59% | 1.42 M | $10.59 |
| Q4 2023 | +315,800 | Add 30.18% | 1.36 M | $12.00 |
| Q3 2023 | -137,800 | Reduce 11.64% | 1.05 M | $7.00 |
| Q2 2023 | +157,200 | Add 15.31% | 1.18 M | $0.01 |
| Q1 2023 | +81,200 | Add 8.59% | 1.03 M | $0.01 |
| Q4 2022 | +185,300 | Add 24.37% | 945,700 | $0.01 |
| Q3 2022 | -207,800 | Reduce 21.46% | 760,400 | $17.02 |
| Q2 2022 | +636,300 | Add 191.71% | 968,200 | $21.48 |
| Q1 2022 | +241,300 | Add 266.34% | 331,900 | $36.99 |
| Q4 2021 | -208,300 | Reduce 69.69% | 90,600 | $45.47 |
| Q3 2021 | +298,900 | New Buy | 298,900 | $63.37 |
| Q2 2021 | -11,800 | Sold Out | 0 | $0.00 |
| Q1 2021 | +11,800 | New Buy | 11,800 | $68.05 |
| Q4 2020 | -170,400 | Sold Out | 0 | $0.00 |
| Q3 2020 | +170,400 | New Buy | 170,400 | $37.94 |
| Q4 2019 | -247,000 | Sold Out | 0 | $0.00 |
| Q3 2019 | -85,800 | Reduce 25.78% | 247,000 | $22.61 |
| Q2 2019 | +65,600 | Add 24.55% | 332,800 | $35.99 |
| Q1 2019 | +123,600 | Add 86.07% | 267,200 | $31.52 |
| Q4 2018 | +48,900 | Add 51.64% | 143,600 | $25.14 |
| Q3 2018 | -126,000 | Reduce 57.09% | 94,700 | $28.85 |
| Q2 2018 | +87,400 | Add 65.57% | 220,700 | $12.24 |
| Q1 2018 | +133,300 | New Buy | 133,300 | $7.97 |
| Q2 2015 | -10,100 | Sold Out | 0 | $0.00 |
| Q1 2015 | +10,100 | New Buy | 10,100 | $5.54 |
Renaissance Technologies (RenTech)'s CareDx Investment FAQs
Renaissance Technologies (RenTech) first purchased CareDx, Inc. (CDNA) in Q1 2015, acquiring 10,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held CareDx, Inc. (CDNA) for 32 quarters since Q1 2015.
Renaissance Technologies (RenTech)'s largest addition to CareDx, Inc. (CDNA) was in Q2 2022, adding 968,200 shares worth $20.8 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC (Rentech), owns 1,105,198 shares of CareDx, Inc. (CDNA), valued at approximately $20.82 M.
As of the Q4 2025 filing, CareDx, Inc. (CDNA) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in CareDx, Inc. (CDNA) was 1,512,700 shares, as reported at the end of Q2 2024.